Literature DB >> 5675421

Insulin delivery rate into plasma in normal and diabetic subjects.

M P Stern, J W Farquhar, A Silvers, G M Reaven.   

Abstract

Removal of insulin-(131)I from plasma was studied in normal and diabetic subjects with both single injection and continuous infusion of isotope techniques. Patients were studied either in the fasting state or during steady-state hyperglycemia produced by a continuous intravenous glucose infusion. Steady-state plasma insulin concentration during these studies ranged from 10 to 264 muU/ml. Labeled insulin specific activity time curves consisted of more than one exponential, indicating that a multicompartmental system for insulin metabolism exists. A mathematical technique which is applicable to non-first order processes was used to calculate the rate at which insulin was lost irreversibly from the plasma insulin pool. A direct, linear relationship was found between insulin irreversible loss rate and plasma insulin concentration over the range of concentrations studied. This linearity implies lack of saturability of the insulin removal mechanism. Since the plasma insulin pool was in a steady state during these studies, insulin irreversible loss rate was equal to the rate at which newly secreted insulin was being delivered to the general circulation. Therefore, these results indicate that changes in plasma insulin concentration result from parallel changes in the rate of insulin delivery and not from changes in the opposite direction of the rate of insulin removal. A wide range of insulin delivery rates was found among patients with similar plasma glucose concentrations, suggesting that there exists considerable variability in responsiveness to endogenous insulin among these patients.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5675421      PMCID: PMC297359          DOI: 10.1172/JCI105884

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

Review 1.  REVIEW: THE USE OF ISOTOPIC STEROIDS FOR THE MEASUREMENT OF PRODUCTION RATES IN VIVO.

Authors:  J F TAIT
Journal:  J Clin Endocrinol Metab       Date:  1963-12       Impact factor: 5.958

2.  Specificity of insulin degradation reaction.

Authors:  N J ELGEE; R H WILLIAMS
Journal:  Diabetes       Date:  1955 Mar-Apr       Impact factor: 9.461

3.  Immunoassay of endogenous plasma insulin in man.

Authors:  R S YALOW; S A BERSON
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

4.  An immunochemical assay of total extractable insulin in man.

Authors:  G M GRODSKY; P H FORSHAM
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

5.  The plasma insulin-I131 in diabetic patients.

Authors:  R E BOLINGER; H J GRADY
Journal:  Ann Intern Med       Date:  1958-04       Impact factor: 25.391

6.  A comparison of the behavior of insulin and insulin labeled with I 131 in serum.

Authors:  G W SCOTT; T E PROUT; J A WEAVER; S P ASPER
Journal:  Diabetes       Date:  1958 Jan-Feb       Impact factor: 9.461

7.  The influence of renal disease on the insulin I-131 disappearance curve in man.

Authors:  J P O'Brien; A R Sharpe
Journal:  Metabolism       Date:  1967-01       Impact factor: 8.694

8.  On insulin immunologic activity in livers and kidneys of mice injected with beef insulin.

Authors:  L V Beck; N Roberts; R Blankenbaker; C King
Journal:  Proc Soc Exp Biol Med       Date:  1966-07

9.  Role of the kidney in the disposal of radioiodinated and nonradioiodinated insulin in dogs.

Authors:  D S Zaharko; L V Beck; R Blankenbaker
Journal:  Diabetes       Date:  1966-09       Impact factor: 9.461

10.  Insulin-I131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects.

Authors:  S A BERSON; R S YALOW; A BAUMAN; M A ROTHSCHILD; K NEWERLY
Journal:  J Clin Invest       Date:  1956-02       Impact factor: 14.808

View more
  21 in total

1.  The degradation of semisynthetic tritiated insulin by perfused mouse livers.

Authors:  P A Halban; C Karakash; J G Davies; R E Offord
Journal:  Biochem J       Date:  1976-11-15       Impact factor: 3.857

2.  Calculation of net insulin secretion and pancreatic blood flow.

Authors:  N M Bor; M T Ercan; M Alvur; C Bekdik; G Oner
Journal:  Pflugers Arch       Date:  1974       Impact factor: 3.657

3.  Effect of nephrectomy on the rate and pattern of the disappearance of exogenous gastrin in dogs.

Authors:  B G Clendinnen; D D Reeder; E N Brandt; J C Thompson
Journal:  Gut       Date:  1973-06       Impact factor: 23.059

4.  Cori cycle activity in man.

Authors:  C Waterhouse; J Keilson
Journal:  J Clin Invest       Date:  1969-12       Impact factor: 14.808

5.  Estimation of pancreatic IRI output rate and its relations to glucose tolerance in normal anasthetized dogs.

Authors:  U Fischer; H Hommel; P Heinke; E Jutzi
Journal:  Diabetologia       Date:  1975-08       Impact factor: 10.122

6.  Studies on persistent circulating immunoreactive glucagon (IRG) and immunoreactive insulin (IRI) found in eviscerated rats with a functional liver.

Authors:  S S Smith; S J Bhathena; D Nompleggi; J C Penhos; L Recant
Journal:  Diabetologia       Date:  1978-03       Impact factor: 10.122

7.  Insulin production rate following glucose ingestion estimated by splanchnic C-peptide output in normal man.

Authors:  W Waldhäusl; P Bratusch-Marrain; S Gasic; A Korn; P Nowotny
Journal:  Diabetologia       Date:  1979-10       Impact factor: 10.122

8.  Kinetics of human connecting peptide in normal and diabetic subjects.

Authors:  O K Faber; C Hagen; C Binder; J Markussen; V K Naithani; P M Blix; H Kuzuya; D L Horwitz; A H Rubenstein; N Rossing
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

9.  Effect of intraduodenal glucose administration on hepatic extraction of insulin in the anesthetized dog.

Authors:  M Kaden; P Harding; J B Field
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

10.  Metabolic clearance rate of radioiodinated human calcitonin in man.

Authors:  R Ardaillou; P Sizonenko; A Meyrier; G Vallée; C Beaugas
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.